Article Details
Retrieved on: 2021-11-06 15:10:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Raymond James raised their target price on NGM Biopharmaceuticals from $39.00 to $42.00 and gave the company a "strong-buy" rating in a research ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here